BioTime Inc.announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks. Derived from human embryonic stem cells but not fully differentiated into specific cell types, each ACTCellerate™ line provides a convenient, highly purified source of progenitor cells that may have applications in drug discovery, research, and the development of therapeutic products.
BioTime’s research products will soon be available to be ordered by researchers through Millipore’s stem cell homepage, www.millipore.com/stemcells. Millipore, which is already a leading supplier of stem cell research reagents, plans a full launch for BioTime’s progenitor cell lines and growth media during the first quarter of 2010.
This work represents a significant step towards the creation of complete cornea tissue that can be used for transplantation and supports prior data showing indications of corneal endothelium generated by ISCO’s collaborators at Sankara NethralayaEye Hospital, India. Such cells by themselves may potentially promote wound healing and regeneration of the cornea and therefore could be used as a standalone medical treatment.
the great indian fraud the week, the week the great indian fraud, the great indian fraud stem cell, great indian fraud stem cell, stem cell retina, great indian fraud about stem cell companies, great india fraud the week, the great indian fraud cord blood, limbal stem cell deficiency frequency in India, isco stem cells, isco cells, international stem cell corporation fraud, great indian fraud stem cells, cornea stemcell, can rosemont hosp repair optic nerces stem cell ect, all india institute medical science delhi optic nerve regeneration.
One of the most advanced research centers for the therapeutic applications of epithelial stem cells in the world, the ‘Stefano Ferrari’ regenerative medicine center at the University of Modena and Reggio Emilia, opened its doors with the ambitious goal of becoming the flagship research center in Italy. It was completely financed by the Modena Savings Bank, which invested 13 million euros for its completion and was inaugurated by Welfare Minister Maurizio Sacconi and Emilia-Romagna President Vasco Errani. It includes a new three floor, 30,000 square meter building (half of which is contamination controlled) at the University of Modena, and will employ 50 researchers and experts when fully operational.
center for regenerative medicine modena italy, university of modernas center for regenerative medicine, centre for regenerative medicine italy, Flexiseg где купить?, stem cell treatment university of modena, University of Modena Italy Center for Regenerative Medicine.